Bumetanide
- Product NDC
- 70860-406
- 11-digit product format
- 708600406
- Labeler code
- 70860
- Product ID
- 70860-406_6c2e0628-10ab-4074-93c7-c895b20c16d8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bumetanide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA074441
- Marketing category
- ANDA
- Marketing start
- 2022-02-08
- Marketing end
- 0000-00-00
- Substance
- BUMETANIDE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-406 | BUMETANIDE INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 4 | Legacy NDC | 20250130_9ec70fd0-080f-48e4-a133-9d581b88c3d8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-406-10 | 70860040610 | 10 VIAL, MULTI-DOSE in 1 CARTON (70860-406-10) > 10 mL in 1 VIAL, MULTI-DOSE | 2022-02-08 | 0000-00-00 | No | No | Current |